Bepirovirsen Achieves Functional Cure in HBV Phase 3 Trial

Published Date: 02 Jul 2026

In patients with chronic hepatitis B infection, bepirovirsen achieves significantly higher rates of functional cure than placebo after discontinuation of nucleoside or nucleotide analog therapy.

Read Full News

Latest News


News All Time

HTTP error: 503HTTP error: 503 HTTP error: 503 HTTP error: 503HTTP error: 503HTTP error: 503 HTTP error: 503
Featured News
Featured Articles
Featured Events
Featured KOL Videos

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot